Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

University of Toronto

$918,000.00

A novel role for IL-18 in the control of the intestinal epithelium during infection and inflammation.

FY 2021-22

Summary
Intestinal inflammation due to infection or diseases like inflammatory bowel disease causes great deal of morbidity and mortality. Our recent work has uncovered a novel pathway in the intestine that protects against infection. Interesting also is that dysregulation of this pathway has been implicated in the inflammatory bowel disease, Crohn's disease. By studying this circuit in the context of infection, we also expect to uncover novel insights into the pathogenesis of Crohn's disease Furthermore, this work will help to define new therapeutic targets that might treat both Crohn's disease and infection.
Program
Project Grant
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
462743
Name
Philpott Dana J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Immunology & Transplantation
Projecttitle
A novel role for IL-18 in the control of the intestinal epithelium during infection and inflammation.
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$918,000
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Colorectal Cancer; Crohn'S Disease; Intestinal Infection; Intestinal Inflammation
Abstract
Intestinal inflammation due to infection or diseases like inflammatory bowel disease causes great deal of morbidity and mortality. Our recent work has uncovered a novel pathway in the intestine that protects against infection. Interesting also is that dysregulation of this pathway has been implicated in the inflammatory bowel disease, Crohn's disease. By studying this circuit in the context of infection, we also expect to uncover novel insights into the pathogenesis of Crohn's disease Furthermore, this work will help to define new therapeutic targets that might treat both Crohn's disease and infection.
Competitiondate
202203
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Philpott, Dana J
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $918,000~ $0~